Asperger syndrome: a proton magnetic resonance spectroscopy study of brain
- PMID: 12365875
- DOI: 10.1001/archpsyc.59.10.885
Asperger syndrome: a proton magnetic resonance spectroscopy study of brain
Abstract
Background: Asperger syndrome (AS; an autistic disorder) is associated with impaired social skills and obsessional/repetitive behavior. Patients with autism have significant abnormalities in the frontal lobe and frontoparietal connectivity. Nobody has examined the relationship between abnormalities in the frontal and parietal lobes and clinical symptoms in people with AS.
Methods: We used in vivo proton magnetic resonance spectroscopy to examine neuronal integrity of the medial prefrontal and parietal lobes in 14 non-learning-disabled adults with AS and 18 control subjects (of similar sex, age, and IQ). We obtained measures of the prefrontal lobe in 11, the parietal lobe in 13, and both lobes in 10 subjects with AS. We measured concentrations and ratios of N-acetylaspartate (NAA), creatine and phosphocreatine (Cr + PCr), and choline (Cho). Levels of NAA, Cr + PCr, and Cho are indicators of neuronal density and mitochondrial metabolism, phosphate metabolism, and membrane turnover. Frontal metabolite levels were correlated with scores on the Yale-Brown Obsessive Compulsive Scale and the Autism Diagnostic Interview.
Results: Subjects with AS had a significantly higher prefrontal lobe concentration of NAA (z = -3.1; P =.002), Cr + PCr (z = -2.2; P =.03), and Cho (z = -2.9; P =.003). Increased prefrontal NAA concentration was significantly correlated with obsessional behavior (tau = 0.67; P =.005); increased prefrontal concentration of Cho, with social function (tau = 0.72; P =.02). We found no significant differences in parietal lobe metabolite concentrations.
Conclusion: Subjects with AS have abnormalities in neuronal integrity of the prefrontal lobe, which is related to severity of clinical symptoms.
Similar articles
-
Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.Schizophr Res. 2003 Nov 1;64(1):63-71. doi: 10.1016/s0920-9964(02)00533-9. Schizophr Res. 2003. PMID: 14511802
-
Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls.AJNR Am J Neuroradiol. 2007 Sep;28(8):1494-8. doi: 10.3174/ajnr.A0625. AJNR Am J Neuroradiol. 2007. PMID: 17846198 Free PMC article.
-
Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.Psychiatry Res. 1995 Nov 10;61(4):193-200. doi: 10.1016/0925-4927(95)02622-5. Psychiatry Res. 1995. PMID: 8748464
-
Prefrontal and medial temporal correlates of repetitive violence to self and others.Biol Psychiatry. 2000 May 15;47(10):928-34. doi: 10.1016/s0006-3223(00)00231-6. Biol Psychiatry. 2000. PMID: 10807966
-
Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. doi: 10.1016/j.pnpbp.2006.03.012. Epub 2006 May 4. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16677749 Review.
Cited by
-
Basal Forebrain Modulation of Olfactory Coding In Vivo.Int J Psychol Res (Medellin). 2023 Oct 10;16(2):62-86. doi: 10.21500/20112084.6486. eCollection 2023 Jul-Dec. Int J Psychol Res (Medellin). 2023. PMID: 38106956 Free PMC article.
-
Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N = 1501).Mol Psychiatry. 2023 Jul;28(7):3092-3103. doi: 10.1038/s41380-023-02079-y. Epub 2023 Apr 28. Mol Psychiatry. 2023. PMID: 37117459
-
The Lack of Alterations in Metabolites in the Medial Prefrontal Cortex and Amygdala, but Their Associations with Autistic Traits, Empathy, and Personality Traits in Adults with Autism Spectrum Disorder: A Preliminary Study.J Autism Dev Disord. 2024 Jan;54(1):193-210. doi: 10.1007/s10803-022-05778-7. Epub 2022 Oct 17. J Autism Dev Disord. 2024. PMID: 36251207 Free PMC article.
-
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.Cannabis Cannabinoid Res. 2023 Feb;8(1):126-137. doi: 10.1089/can.2021.0129. Epub 2021 Dec 6. Cannabis Cannabinoid Res. 2023. PMID: 34874191 Free PMC article.
-
N-Acetylaspartyl-Glutamate Metabolism in the Cingulated Cortices as a Biomarker of the Etiology in ASD: A 1H-MRS Model.Molecules. 2021 Jan 28;26(3):675. doi: 10.3390/molecules26030675. Molecules. 2021. PMID: 33525414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials